These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23894282)

  • 1. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
    Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
    PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
    Chen Q; Shi R; Liu W; Jiang D
    PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the interactions between the associations of common genetic variants on 2q35 and 16q12 with breast cancer risk.
    Fan YL; Guo ZJ; Zhu P; Yang XJ; Yang XD; Yu B; Li LH
    Neoplasma; 2015; 62(2):315-25. PubMed ID: 25591598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
    Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
    PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.
    Pan W; Cheng H; Zhang J; Yang Z; Lin M
    Clin Breast Cancer; 2024 Aug; 24(6):552-561. PubMed ID: 38641470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
    Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
    Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(42):68002-68011. PubMed ID: 27634905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2q35-rs13387042 variant and the risk of breast cancer: a case-control study.
    Nesaei A; Naderi Ghale-Noie Z; Khorshid Shamshiri A; Afzaljavan F; Rivandi M; Tajbakhsh A; Homaei Shandiz F; Pasdar A
    Mol Biol Rep; 2022 May; 49(5):3549-3557. PubMed ID: 35445312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
    Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
    PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
    Wyszynski A; Hong CC; Lam K; Michailidou K; Lytle C; Yao S; Zhang Y; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; González-Neira A; Benitez J; Neuhausen SL; Brenner H; Dieffenbach AK; Meindl A; Schmutzler RK; Brauch H; ; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; ; Wu AH; Van Den Berg D; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Couch FJ; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Dumont M; Teo SH; Wong TY; Kristensen V; Zheng W; Long J; Winqvist R; Pylkäs K; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Klevebring D; Czene K; Hooning MJ; van den Ouweland AM; Darabi H; Shu XO; Gao YT; Cox A; Blot W; Signorello LB; Shah M; Kang D; Choi JY; Hartman M; Miao H; Hamann U; Jakubowska A; Lubinski J; Sangrajrang S; McKay J; Toland AE; Yannoukakos D; Shen CY; Wu PE; Swerdlow A; Orr N; Simard J; Pharoah PD; Dunning AM; Chenevix-Trench G; Hall P; Bandera E; Amos C; Ambrosone C; Easton DF; Cole MD
    Hum Mol Genet; 2016 Sep; 25(17):3863-3876. PubMed ID: 27402876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.
    Wu S; Cai J; Wang H; Zhang H; Yang W
    PLoS One; 2013; 8(8):e72526. PubMed ID: 23977314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
    Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
    Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
    Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
    Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.
    Wu X; Xu QQ; Guo L; Yu CT; Xiong YY; Wei ZY; Huo R; Li ST; Shen L; Niu JM; Liu L; Lin Y; He L; Qin SY
    PLoS One; 2013; 8(6):e65206. PubMed ID: 23785413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Gao F; Ge R
    Clin Breast Cancer; 2019 Oct; 19(5):e596-e610. PubMed ID: 31324582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.